Our community narratives are driven by numbers and valuation.
Novonesis (formerly Novozymes) rides two big shifts: more demand for healthier foods and cleaner household products, plus a growing push for biofuels—especially in faster-growing emerging markets. The key question is whether these newer markets and early-stage biofuel projects scale up quickly enough to justify today’s optimism, or whether currency swings and heavy reinvestment slow progress.Read more

Novozymes sells enzymes and microbes used in everything from food and dairy to detergents and biofuels, and demand for cleaner products and more sustainable production could keep the business growing. But tougher rules and rising competition—especially in emerging markets—could slow progress and make it harder to keep improving profits.Read more

SP Group is betting on new facilities in the US and Poland to meet growing demand for specialised parts used in healthcare and clean energy equipment, which could make its sales steadier over time. But it still depends heavily on plastics, and tighter rules, shifting customer preferences, and big spending needs could make the path bumpier than it looks.Read more

Catalysts About Novozymes Novozymes develops and manufactures enzyme based and microbial biosolutions that improve productivity, sustainability and health outcomes for customers across food, household care, agriculture and industrial markets. What are the underlying business or industry changes driving this perspective?Read more
